Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF AUGUST 06, 2010 FBO #3177
SOLICITATION NOTICE

65 -- Biological Product

Notice Date
8/4/2010
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
325414 — Biological Product (except Diagnostic) Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
 
ZIP Code
20892-7902
 
Solicitation Number
NHLBI-PB-(HL)-2010-254-DDC
 
Archive Date
8/24/2010
 
Point of Contact
Deborah - Coulter, Phone: (301) 435-0368
 
E-Mail Address
dc143b@nih.gov
(dc143b@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation number is NHLBI-PB-(HL)-2010-254-DDC and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2005-44 (7/2010). The North American Industry Classification (NAICS) Code is 325414 and the business size standard is 500. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13. However, this solicitation is not set aside for small business. It is the intent of the National Institutes of Health (NIH) National Heart, Lung and Blood Institute to procure the following products from Bio-Rad Laboratories, 2000 Alfred Nobel Drive, Hercules, CA 94547. 1.171A4007M - Bio-Plex Pro Human Acute Phase 5-Plex Panel. 1 x 96-well, includes coupled beads, detection antibodies, and standards for detecting 5 human acute phase biomarkers, requires acute phase reagent kit and diluents kit, quantity 10 each. 2.171A4009M - Bio-Plex Pro Human Acute Phase 4-Plex Panel. 1 x 96-well, includes coupled beads, detection antibodies, and standards for detecting 4 human acute phase biomarkers, requires acute phase reagent kit and diluents kit, quantity 10 each 3.171304051 - Bio-Plex Pro Human Acute Phase Reagent Kit. 10 x 96-well, includes 10 x 96-well filter plate, assay and wash buffers, detection antibody diluents, streptavidin-PE, sealing tape, quantity 1 each 4.171305050 - Bio-Plex Pro Human Acute Phase Diluents Kit. 1 x 96-well, includes 96-well filter plate, 10 ml serum-based diluents, 300 ml serum free diluents; for one 5-plex and one 4-plex assay, quantity 10 each 5.MF0005KMII- Bio-Plex Pro Human Cytokine 21-plex Assay, 1x96. Includes coupled magnetic beads, detection antibodies, standards, assay buffer, wash buffer, detection antibody diluents, streptavidin-PE, filter plate, sealing tape, standard diluents, quantity 10 each 6.171D10502 - Bio-Plex Pro Human Cytokine Standards Group II 23-Plex. Package of 50 lot-matched vials, cytokine standard for detecting 23 human cytokines, quantity 1 each 7.M500KCAF0Y - Bio-Plex Pro Human Cytokine 27-plex Assay, 1x96. Includes coupled magnetic beads, detection antibodies, standards, assay buffer, wash buffer, detection antibody diluents, streptavidin-PE, filter plate, sealing tape, standard diluents, quantity 10 each 8.171A4001M - Bio-Plex Pro Human Diabetes 12-Plex Panel. 1 x 96-well, includes coupled beads, detection antibodies, and standards for detecting 12 human diabetes biomarkers, requires diabetes reagent kit and diluents kit, quantity 10 each 9.171305040 - Bio-Plex Pro Diabetes Diluents Kit.1x 96- well, includes 96-well filter plate, 70 ml serum-based diluents, 25 ml serum-free diluents; for one 12-plex and two singleplex assays, quantity 10 each 10. Bio-Plex Pro Diabetes Reagent Kit. 10 x 96 well, includes 10 x 96 well filter plate, assay and wash buffer, detection antibody diluents, streptavidin-PE, sealing tape, quantity 1 each 11.Bio-Plex Pro human Diabetes Standards, package of 50 lot-matched vials, diabetes standard for detecting 12 human diabetes biomarkers, quantity 1 each The sole source determination is based on the fact the National Health, Lung, and Blood Institute (NHLBI) Center of Human Immunology, depends heavily on detection of cytokines present on the plasma. The Center has been using detection based on beads assay using a bioplex instrument from Bio-Rad. The Bio-Rad luminex kits are compatible with the Government’s existing Bio-Rad luminex instrument which currently allows the Government to run magnetic beads for cytokine detection. Bio-Rad is the only company that proposes up to 69 different analytes coupled to magnetic beads. The Offeror must include a completed copy of the following provisions: 1) FAR Clause 52.212-1 Instructions to Offerors Commercial; 2) As stated in FAR Clause 52.212-2 (a), The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: Technical Evaluation and Price. 3) FAR Clause 52.212-3, Offeror Representations and Certifications Commercial Items; 4) FAR Clause 52.212-4, Contract Terms and Conditions Required To Implement Statues or Executive Orders Commercial Items, Contract Terms and Conditions Commercial Items; and 5) FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items Deviation for Simplified Acquisitions. Only one responsible source and no other supplies or services will satisfy agency requirement. Interested parties may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations however; all responses received within five (5) days from publication date of this synopsis or by August 9, 2010 7:30am Eastern Standard Time. A determination by the Government not to compete this proposed acquisition is based upon responses to this notice and is solely for the purpose of determining whether to conduct a competitive acquisition. The offeror must include in their quotation, the unit price, the list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. Note: In order to receive an award from the NHLBI contractors must have a valid registration in the Central Contractor Registration (CCR) www.ccr.gov. The clauses are available in full text at http://www.arnet.gov/far. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency. Quotations must be submitted in writing to the National Heart, Lung and Blood Institute 6701 Rockledge Blvd., Room Suite 6100, Bethesda, Maryland 20892, Attention: Deborah Coulter. coulterd@nhlbi.nih.gov. Faxed copies are not accepted. Emails are accepted.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/NHLBI-PB-(HL)-2010-254-DDC/listing.html)
 
Place of Performance
Address: NIH, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN02229172-W 20100806/100804235511-3fd7cc0f5d6b54dbfcff568e1dc82136 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.